Mirae Asset Global Investments
VIR icon

Mirae Asset Global Investments’s Vir Biotechnology VIR Stock Holding History

Mirae Asset Global Investments’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.9K Sell
7,543
-655
-8% -$6.23K ﹤0.01% 1293
2026
Q1 		$73.5K Buy
8,198
+1,437
+21% +$11.4K ﹤0.01% 1228
2025
Q4 		$40.8K Buy
6,761
+1,390
+26% +$8.28K ﹤0.01% 1437
2025
Q3 		$30.7K Buy
5,371
+31
+0.6% +$159 ﹤0.01% 1429
2025
Q2 		$26.9K Buy
5,340
+804
+18% +$4.31K ﹤0.01% 1355
2025
Q1 		$30.4K Sell
4,536
-53
-1% -$471 ﹤0.01% 1330
2024
Q4 		$34.3K Sell
4,589
-353
-7% -$2.78K ﹤0.01% 1330
2024
Q3 		$37.2K Buy
4,942
+880
+22% +$7.64K ﹤0.01% 1350
2024
Q2 		$36K Sell
4,062
-45,463
-92% -$436K ﹤0.01% 1302
2024
Q1 		$904K Sell
49,525
-163,377
-77% -$1.66M ﹤0.01% 1592
2023
Q4 		$2.14M Buy
212,902
+155,196
+269% +$1.42M ﹤0.01% 1226
2023
Q3 		$541K Buy
57,706
+3,628
+7% +$51.7K ﹤0.01% 1844
2023
Q2 		$1.33M Buy
54,078
+4,637
+9% +$116K ﹤0.01% 1410
2023
Q1 		$1.15M Buy
49,441
+10,439
+27% +$267K ﹤0.01% 1469
2022
Q4 		$987K Buy
39,002
+2,395
+7% +$58.7K ﹤0.01% 1503
2022
Q3 		$706K Sell
36,607
-75,917
-67% -$1.93M ﹤0.01% 1678
2022
Q2 		$8.21M Buy
+112,524
New +$2.63M 0.02% 673
2021
Q3 		– Sell
-4,269
Closed -$202K – 1784
2021
Q2 		$202K Buy
+4,269
New +$194K ﹤0.01% 1652

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
SAI
Savvy Advisors Inc New York $4.71B AUM 25.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return

Mirae Asset Global Investments's VIR Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Vir Biotechnology (VIR) stake by 8% in Q2 2026, selling an estimated $6.23K and leaving 7,543 shares worth $76.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1293.

Mirae Asset Global Investments first reported a position in VIR in Q2 2021 and has held it in 18 quarters since. The position peaked at $8.21M in Q2 2022. 82 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Mirae Asset Global Investments held 7,543 shares of Vir Biotechnology worth $76.9K as of Q2 2026.
  • Mirae Asset Global Investments sold 655 Vir Biotechnology shares in Q2 2026, an estimated $6.23K.
  • Vir Biotechnology made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1293 holding.
  • Mirae Asset Global Investments first reported a position in Vir Biotechnology in Q2 2021 and has held it in 18 quarters since.
  • Mirae Asset Global Investments's Vir Biotechnology position peaked at $8.21M in Q2 2022.
  • 82 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.